Catalent and EuropaBio On-Demand Webinar

Then and Now – Delivering a Successful Therapeutic to Patients

AVAILABLE ON-DEMAND

Event Details:

In today’s whirlwind of diagnostics, vaccines and therapeutics, we take a step back and look at how the world of development and manufacturing of biologics has evolved over the last 25 years, bringing together EuropaBio Members and 25th Anniversary Sponsor, Catalent.

We look back at changing experience from the last quarter of a century in the pathway to patients, plus how the latest advanced technologies translate into effective pre-clinical and clinical development and manufacturing. Hear expert presentations from EuropaBio Members and Catalent Biologics, before a detailed Q&A session with the audience to review all aspects of the development of a successful biologic in 2021.

FEATURED SPEAKERS

First Name*

Last Name*

Email*

Job Level*

Company*

Country*

Phone

Primary Area of Interest*

Reason for Interest*

Keep Me Informed (Opt In)

Behzad Mahdavi, Ph.D., MBA

Vice President of Open Innovation, Biologics, Cell and Gene Therapy

With over 20 years’ experience in developing and implementing impactful growth strategies in the biopharmaceutical industries, Dr. Mahdavi joined Catalent in 2020 after a 13-year career at Lonza, where he held the role of Vice President Strategic Innovation & Alliances, and various board-level positions at other innovative companies. Prior to joining Lonza, he was Chief Executive Officer of SAM Electron Technologies, a venture capital-backed company in the life sciences field. He holds a doctorate in chemistry from the University of Sherbrooke, Canada, and also has a master’s in business administration from the University of Quebec in Montreal.

Tine Lewi, Ph.D.

Scientific Director, Janssen R&D/Clinical Innovation.

Dr. Lewi is leading Patient Data For Research initiatives within Janssen Clinical Innovation, introducing novel projects in the area of data science. She has worked for several years in data management and analytics solution development and engages in RWD initiatives to optimise clinical research across the R&D lifecycle. Dr. Lewi has a special interest in using health data for early diagnosis and disease interception, understanding disease trajectories and treatment optimization through RWD. She has a background in medical informatics and applied economics and obtained a doctorate on patient insights and health communication for disease prevention.

By submitting this form you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement.